Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multiple mechanisms underlie the aberrant expression of the human kallikrein 6 gene in breast cancer

1 Jan 2006

Abstract excerpt

Human kallikrein 6 (KLK6) was identified based on its transient upregulation in a primary breast tumor and its subsequent silencing in a metastatic tumor from the same patient. The molecular mechanism(s) underlying the deregulated expression of KLK6 during cancer progression are currently unknown. Here, we provide evidence that aberrant expression of KLK6 is regulated at the level of transcription by multiple...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Coagulation, Bradykinin, Polyphosphates, and Angioedema

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 16800739
DOI: 10.1515/bc.2006.097

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multiple mechanisms underlie the aberrant expression of the human kallikrein 6 gene in breast cancerPMID 16800739Read ↗

Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspectsSemantic proximity Read ↗

The epigenetic basis for the aberrant expression of kallikreins in human cancersSemantic proximity Read ↗

In silico analysis of the human kallikrein gene 6.Semantic proximity Read ↗

KLK12 Is a Novel Serine Protease and a New Member of the Human Kallikrein Gene Family—Differential Expression in Breast CancerSemantic proximity Read ↗

Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients.Semantic proximity Read ↗

KLK6‐regulated miRNA networks activate oncogenic pathways in breast cancer subtypesSemantic proximity Read ↗

Kallikrein gene downregulation in breast cancerSemantic proximity Read ↗

The KLK7 (PRSS6) gene, encoding for the stratum corneum chymotryptic enzyme is a new member of the human kallikrein gene family — genomic characterization, mapping, tissue expression and hormonal regulationSemantic proximity Read ↗

Clinicopathologic and Biological Significance of Kallikrein 6 Overexpression in Human Gastric CancerSemantic proximity Read ↗

Expression analysis of the human kallikrein 7 (KLK7) in breast tumors: a new potential biomarker for prognosis of breast carcinomaSemantic proximity Read ↗

The emerging roles of human tissue kallikreins in cancerSemantic proximity Read ↗

Epigenetic Silencing of the Tumor Suppressor Cystatin M Occurs during Breast Cancer ProgressionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.